Drug class
Sympathomimetic amine; vasoconstrictor used in historical antimigraine combinations
Mechanism of action
Acts as an indirectly and directly sympathomimetic amine, promoting adrenergic vasoconstriction through release of noradrenaline and stimulation of peripheral alpha-adrenergic signalling. The proposed antimigraine effect is related to cranial vasoconstriction; its clinical role is historical and product-specific.
General use cases
- Historically used for acute migraine or tension-type headache in fixed-dose combinations with analgesic and sedative components in selected countries. Current availability and authorisation vary by jurisdiction.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
